Osaic Holdings
KRYS icon

Osaic Holdings’s Krystal Biotech KRYS Stock Holding History

Osaic Holdings’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Buy
10,498
+10,075
+2,382% +$3.01M ﹤0.01% 1734
2026
Q1 		$109K Sell
423
-6,309
-94% -$1.68M ﹤0.01% 4615
2025
Q4 		$1.66M Buy
6,732
+6,344
+1,635% +$1.34M ﹤0.01% 2241
2025
Q3 		$61.9K Sell
388
-5
-1% -$748 ﹤0.01% 5172
2025
Q2 		$54.3K Buy
393
+115
+41% +$16.9K ﹤0.01% 4986
2025
Q1 		$50.1K Sell
278
-28
-9% -$4.71K ﹤0.01% 4714
2024
Q4 		$47.9K Buy
306
+19
+7% +$3.37K ﹤0.01% 4734
2024
Q3 		$52.2K Buy
287
+11
+4% +$2.12K ﹤0.01% 4717
2024
Q2 		$50.7K Buy
276
+24
+10% +$4.03K ﹤0.01% 4665
2024
Q1 		$44.8K Sell
252
-473
-65% -$65.7K ﹤0.01% 4826
2023
Q4 		$89.9K Sell
725
-204
-22% -$22.6K ﹤0.01% 4507
2023
Q3 		$108K Buy
929
+533
+135% +$65K ﹤0.01% 4450
2023
Q2 		$46.5K Buy
396
+261
+193% +$26.6K ﹤0.01% 4987
2023
Q1 		$10.8K Buy
135
+20
+17% +$1.57K ﹤0.01% 5933
2022
Q4 		$9K Buy
115
+6
+6% +$445 ﹤0.01% 6000
2022
Q3 		$8K Buy
109
+12
+12% +$867 ﹤0.01% 6130
2022
Q2 		$6K Sell
97
-3
-3% -$187 ﹤0.01% 6386
2022
Q1 		$7K Buy
100
+96
+2,400% +$5.99K ﹤0.01% 6329
2021
Q4 		$0 Sell
4
-615
-99% -$35.8K ﹤0.01% 7485
2021
Q3 		$32K Buy
+619
New +$36.6K ﹤0.01% 5442

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Osaic Holdings's KRYS Position: Q2 2026 in Review

Osaic Holdings increased its Krystal Biotech (KRYS) stake by 2,382% in Q2 2026, buying an estimated $3.01M and bringing the position to 10,498 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Osaic Holdings first reported a position in KRYS in Q3 2021 and has held it in 20 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Osaic Holdings held 10,498 shares of Krystal Biotech worth $3.9M as of Q2 2026.
  • Osaic Holdings bought 10,075 Krystal Biotech shares in Q2 2026, an estimated $3.01M.
  • Krystal Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #1734 holding.
  • Osaic Holdings first reported a position in Krystal Biotech in Q3 2021 and has held it in 20 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.